Device Trial Radar · NCT04410146
The SQUID Trial for the Embolization of the Middle Meningeal Artery for Treatment of Chronic Subdural Hematoma (STEM)
Last checked: Nov 19, 2026Latest source record: Jun 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
319
Actual
Start
Nov 1, 2020
Primary completion
May 23, 2024
Study completion May 23, 2024
Sponsor
- Lead sponsor
- Balt USANot on our public-company list
- Sponsor type
- Industry
- First posted
- Jun 1, 2020
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 30 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
STEM Study is a pivotal, international, multi-center, prospective, randomized (1:1) controlled trial designed to provide an assessment of the safety and effectiveness of Middle Meningeal Artery (MMA) embolization with SQUID for the management of Chronic Subdural Hematoma (cSDH)
Conditions
- Subdural Hematoma, Chronic
Interventions
SQUID EmbolizationDevice
Embolization of the Middle Meningeal Artery using the SQUID non-adhesive liquid embolic agent
SQUID Embolization and Surgical EvacuationDevice
Embolization of the Middle Meningeal Artery using the SQUID non-adhesive liquid embolic agent and the surgical of the sub-dural hematoma
Surgical EvacuationProcedure
Surgical evacuation of the sub-dural hematoma
Standard Medical ManagementOther
Standard Medical Management
Primary outcomes
What the sponsor says the trial is designed to measure.
- Primary Effectiveness Endpoint-Number of Participants With Treatment FailureTime frame: On 180-day from intervention
- Primary Safety Endpoint-Number of Participants With Major Disabling Stroke or Any Death Within 30 Days of InterventionTime frame: Within 30-days from intervention
Locations
32 sites in 4 countries. Site status is shown where the registry gives one.
Barrow Neurological Institute
Phoenix, Arizona
Carondolet St. Joseph's
Tucson, Arizona
Riverside Community Hospital
Riverside, California
29 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.